Answer
The most commonly reported adverse reactions with Steglatro across the clinical programme were urinary tract infections, vulvovaginal mycotic infection and other female genital mycotic infections.
Sources for this answer
- Steglatro 5 mg and 15 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.8 Undesirable effects · Version 9Document updated
Sources checked